Afatinib

Catalog #
27009
$115 *
Size: 25 mg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Afatinib, also known as BIW-2992, is an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinases. Afatinib suppresses EGF-induced EGFR phosphorylation and cellular proliferation in various cell lines, including EGFR-overexpressing and HER2-expressing cell lines A431, NIH-3T3-HER2, NCI-N87 and BT-474.

Synonyms
BIW-2992
Product Info
Storage and Usage
Citations
Purity

≥95% by HPLC.

Format
White crystalline powder.
Formula
C24H25ClFN5O3
MW
485.94 Da
Solubility
Soluble in DMSO at 200 mg/ml; soluble in ethanol at 25 mg/ml; very poorly soluble in water; maximum solubility in plain water is estimated to be about 50-100 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility.
Biological Activity
Afatinib inhibited the EGFR kinase (IC50 = 15 nM) using BPS Bioscience EGFR assay performed using 10 µM ATP and 0.2 mg/ml poly-(Glu-Tyr). Activity was measured by Kinase-Glo Plus reagents (Promega).
CAS Registry #
439081-18-2
References
Eskens, F.A., et al. Br. J. Cancer 98: 80-85 (2008).